JOSEPH JANKOVIC to Tardive Dyskinesia
This is a "connection" page, showing publications JOSEPH JANKOVIC has written about Tardive Dyskinesia.
Connection Strength
4.946
-
Real-world experience with VMAT2 inhibitors in Tourette syndrome. J Neurol. 2023 Sep; 270(9):4518-4522.
Score: 0.829
-
Oromandibular tics associated with Tourette syndrome. J Neurol. 2023 May; 270(5):2591-2596.
Score: 0.809
-
Treatment of Tardive Dyskinesia. Neurol Clin. 2020 05; 38(2):379-396.
Score: 0.660
-
Treatment of Tardive Dyskinesia: A General Overview with Focus on the Vesicular Monoamine Transporter 2 Inhibitors. Drugs. 2018 04; 78(5):525-541.
Score: 0.578
-
Tardive syndromes. J Neurol Sci. 2018 06 15; 389:35-42.
Score: 0.572
-
Functional (psychogenic) stereotypies. J Neurol. 2017 Jul; 264(7):1482-1487.
Score: 0.548
-
Drug-Induced Dyskinesia, Part 2: Treatment of Tardive Dyskinesia. Drugs. 2016 May; 76(7):779-87.
Score: 0.506
-
Expanding phenomenologic heterogeneity of tardive syndromes: Time for an updated assessment tool. Parkinsonism Relat Disord. 2020 08; 77:141-145.
Score: 0.169
-
The nosology of tardive syndromes. J Neurol Sci. 2018 06 15; 389:10-16.
Score: 0.143
-
Dopamine depleters in the treatment of hyperkinetic movement disorders. Expert Opin Pharmacother. 2016 Dec; 17(18):2461-2470.
Score: 0.132